Aristotle Atlantic Partners, LLC's Core Equity Strategy outperformed the S&P 500 in Q2 2024, with Boston Scientific Corporation being highlighted as a top stock pick. The company saw significant revenue growth, but the strategy favors AI stocks for higher returns.